Pharma in Brief

AUGUST 9, 2021

Terms and conditions would be imposed after discussions with the manufacturer and would obligate them to take steps to manage risks and resolve uncertainties. An RMP summarizes the risks of a drug and the pharmacovigilance activities and other measures that a manufacturer puts in place to monitor and manage any identified risks.

Regulation 98

Regulation Drugs Manufacturing Production 98

The Pharma Data

DECEMBER 28, 2020

This further highlights Amphastar’s considerable abilities to bring complex generic drugs to the market, and more specifically, our strong peptide capabilities.” sales of brand products containing glucagon for injection, 1 mg, were approximately $306 million for the 12 months ended September 30, 2020. Company Information.

Bioequivalency 52

Bioequivalency Production Sales Marketing 52

XTalks

AUGUST 2, 2023

Most of the company’s revenue comes from the manufacture and sale of biopharmaceutical products. Comirnaty was first approved by the US Food and Drug Administration (FDA) in August 2021 for individuals over the age of 16. It contains the antiviral medications nirmatrelvir and ritonavir. billion the drug generated in 2021.

Sales 98

Sales Manufacturing FDA Approval Life Science 98

Pharmaceutical Technology

DECEMBER 4, 2022

For example, the first-to-market status was beneficial when it came to insulin biosimilars. Also, some biosimilars contain citrate, while others like Abrilada do not. Low-concentration versions of Hadlima and Hyrimoz, produced by Sandoz, Novartis’s generic subsidiary, contain citrate. It is just a matter of time.”.

Marketing 262

Marketing Pharmacy Production Branding 262